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“Some time next year an embryo will
be cloned from a human adult. It will
be implanted in the uterus of a young
woman selected with some care for
her wide pelvis and robust health. A
son will be born at the dawn of the
third millennium. Neither angels nor
news wires are likely to herald the
birth. The father — an Asian
plutocrat, South American kleptocrat
or aging Western rock star — won’t be
looking for publicity. He will be
looking for everlasting life.”
So declared a piece in Forbes
magazine on 11 January. All this is
due to a series of breathtaking
advances, crowned this past year by
the isolation of embryonic stem cells.
“The key breakthroughs have
already occurred,” the opinion piece
declared, “all the rest now is detail.”
This, the writer announced darkly, is
the dawn of “bioatomic power.”
Indeed, many journalists were
breathless about the potential of stem
cells. They can’t be cloned into new
humans, but they can in theory be
cultivated and cajoled to form tidy
masses of cells of any type, seemingly
limited only by the imagination of the
people in white coats. Results flowed
in fast and furiously. The first
splashes came in November, when
two teams — both funded by Geron
Corporation — announced they had
isolated stem cells from embryos and
fetuses. “Isolating these cells has
been a Holy Grail for developmental
biologists for years,” declared USA
Today, dusting off a metaphor as
musty as the knights of Camelot.
US News & World Report ushered
in the news by noting, “these tiny
bits of protoplasm are capable of
developing into all 210 different
kinds of tissue found in the human
body, and they offer the hope of one
day serving as a source of universal
spare body parts, allowing doctors to
treat a wide array of diseases more
effectively.” The report says cell lines
will soon be cooking away to provide
tissue culture for testing new drugs.
Curiously, almost nobody noted
that the researchers have thus far not
been able to culture distinct lines
from a single cell, which a biologist
would consider a fairly basic test to
demonstrate that these cells are,
indeed, the wondrous stem cells that
will be able to deliver all things to all
people. Skepticism, such as there
was, was focused elsewhere.
“The dawn of bioatomic power”
“Hold the Champagne,” declared
the New Scientist. “[M]uch needs to
be done to prove that their cultures
have any therapeutic value — and
that tissue grown in this way would
be safe.” New Scientist, among others,
quoted Roger Pedersen of UCSF,
noting that nobody has a clue about
how to turn these undifferentiated
cells into cells of a desired type.
“That’s like an astronomer saying,
‘Give me hydrogen, and I will build
you a universe’,” he told US News &
World Report.
In an article written for the online
journal, Slate, and reprinted in the
Sacramento Bee, William Saletan
argued that journalists, politicians
and scientists are all missing the
point about this research. While they
are arguing about whether it’s all
legal and proper, he says, they aren’t
considering whether what’s already
legal is indeed ethical. “We can cure
diseases, immortalize cells and
theoretically live forever without the
nasty old moral problem of
‘harvesting’ fetuses.” But, Saletan
warns: “The immediate threat posed
by the unraveling of the old physical
and moral distinctions — between
human beings and human parts,
organisms and nonorganisms, subjects
and objects — is that private interests
will come to own the stuff of which
we’re made.”
Indeed, Saletan was commenting
about a Congressional hearing
triggered by yet another splashy
stem-cell announcement: researchers
at Advanced Cell Technology in
Massachusetts asserted that they had
created stem cells by injecting
human DNA into a cow egg. This
seminal piece of work was published,
not in a scientific journal, but in the
New York Times. “The company said
yesterday that it had achieved the
feat with one cell almost three years
ago. Michael D. West, Advanced Cell
Technology’s chief executive, said
that he was announcing the work to
test its public acceptability.”
The announcement was roundly
criticized for lacking the supporting
scientific evidence one would expect
(the major documentation was a
photograph). And the company’s
motives quickly came into question.
The Worcester Sunday Telegram
(Massachusetts) raised the matter of
financial manipulation, noting that
Geron’s stock has reacted strongly to
business announcements. (Advanced
Cell Technology has not issued
stock.) “West, who coincidentally was
a founder of Geron, had one word for
the suggestion that Advanced Cell
Technology announced its embryonic
stem cell research to entice financial
investment: ‘baloney’.”
Many reports did question the
viability of such cells — if indeed
they were produced — as they would
evidently contain cow mitochondria.
But, as always, there are those who
don’t care about all those messy
details. The Arizona Republic sent a
reporter to a New Age conference in
Las Vegas, Nevada, where all this
talk of stem cells was met with a
sense of simple awe. The report
noted that one entrepreneur has 35
frozen human heads or bodies,
preserved for eternal life. “Science
seems to be catching up with the
idea that something can be done
with them.”
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